In this blog article, Dr. Dan Milner, Chief Medical Officer of the American Society for Clinical Pathology, discusses his experience about his participation in the 2022 Summit on Cancer Health Disparities held on April 29-May1, 2022.
In this blog article, Dr. Dan Milner, Chief Medical Officer of the American Society for Clinical Pathology, discusses his experience about his participation in the 2022 Summit on Cancer Health Disparities held on April 29-May1, 2022.
2022 Summit on Cancer Health Disparities 2023 Precision Oncology Summit ASCO ASCO23 award Binaytara foundation Binaytara Foundation education academy BTF cancer cancer care cancer disparities cancer research cancer survival cancer treatment cancer treatment in Nepal Cellular therapy CME community oncologists conference continuing education Dr. Binay Shah Dr. Rubina Suwal Dr Anish Shah Dr Shipra Gandhi ESMO 2023 Expert Opinion faculty highlight FDA FDA Approval FDA approved head & neck cancer surgery in Nepal healthcare equity hematological malignancies hematologic malignancies leukemia Lung cancer lymphoma melanoma multiple myeloma Nepal cancer care oncology oncology CME Opinion SCHD Volunteer
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug Administration granted accelerated approval for tovorafenib (Ojemda,
MoreBy: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug Administration granted regular approval to tisotumab vedotin-tftv
MoreBy: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug Administration granted approval for lutetium Lu 177
MoreBy: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug Administration granted approval to a potent oral
MoreBy: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 22, 2024, the U.S. Food and Drug Administration granted approval for nogapendekin alfa inbakicept-pmln
More